We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Synovial Fluid Harbors Postsurgical Bacterial Biofilm

By HospiMedica International staff writers
Posted on 01 Apr 2015
A new study suggests that prophylactic antibiotics given before joint replacement surgery are insufficient to prevent bacterial contamination. More...


Researchers at Thomas Jefferson University (Philadelphia, PA, USA), The US National Institutes of Health (NIH, Bethesda, MD, USA), and other institutions conducted a study to understand why joint infections persist after joint replacement surgery, despite standards of care designed to stop them. To do so, they collected clinical samples of synovial fluid that contained preoperative cefazolin in high antibiotic levels, in some cases in concentrations that far exceed the expected bactericidal levels.

The researchers then added Staphylococcus aureus bacteria to the synovial fluid samples. Not only were the bacteria not eradicated, they were able to form biofilm-like clumps and colonize model implant surfaces, such as titanium pins. The researchers found that the biofilm-like clumps were able to form because bacteria embed themselves in a protective mesh of proteins that resist penetration of antibiotics. They also found that the bacteria slowed down their growth, making them even less susceptible to the antibiotics. The study was published in the April 2015 issue of Antimicrobial Agents and Chemotherapy.

“The persistence of these bacteria in synovial fluid containing antibiotics may be one reason that joint infection is so difficult to cure,” concluded lead author Sana Dastgheyb, PhD, and colleagues. “The next step is to see how we can disperse these mega-clusters of buried bacteria. If we can provide a window for antibiotics to carry out their intended function, we can move towards a clinical model and ultimately cure joint infection.”

Antibiotic prophylaxis is standard for patients undergoing surgical procedures. But despite the wide use of antibiotics, breakthrough infections still occur at a rate of about 1%; in the setting of total joint arthroplasty, such infections can be devastating. Based on the study, the researchers suggest that current prophylactic antibiotic choices, despite high penetration into the synovial fluid, may need to be reexamined.

Related Links:

Thomas Jefferson University
US National Institutes of Health



Gold Member
12-Channel ECG
CM1200B
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Mammography System (Analog)
MAM VENUS
Semi‑Automatic Defibrillator
Heart Save AED (ED300)
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.